Related Experiment Video
Updated: Oct 30, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Development and validation of a clinical and genetic model for predicting risk of severe COVID-19
Gillian S Dite1, Nicholas M Murphy1, Richard Allman1
1Genetic Technologies Ltd, Fitzroy, Victoria, Australia.
Insights
A new clinical and genetic model accurately predicts severe coronavirus disease 2019 (COVID-19) risk. This tool is vital for personalized risk assessment, especially where vaccination is limited or refused.
Area of Science:
- Genetics
- Epidemiology
- Biostatistics
Background:
- Clinical and genetic risk factors for severe coronavirus disease 2019 (COVID-19) are often analyzed separately.
- Understanding the combined effect of these factors is crucial for accurate risk prediction.
- Existing models may not fully capture the complex interplay of clinical and genetic predispositions to severe COVID-19.
Purpose of the Study:
- To develop and validate a combined clinical and genetic model for predicting severe COVID-19 risk.
- To assess the predictive performance of the new model compared to existing tools.
- To provide a tool for individual risk stratification in diverse populations.
Main Methods:
- Utilized multivariable logistic regression on a large dataset of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive participants from the UK Biobank.
- A 70% training dataset was used for model development, with the remaining 30% reserved for validation.
- Model performance was evaluated using discrimination (Area Under the Receiver Operating Characteristic Curve) and calibration metrics.
Main Results:
- The developed clinical and genetic model demonstrated significant association with severe COVID-19 in the validation dataset (OR=1.77 per quintile).
- The model achieved acceptable discrimination with an Area Under the ROC Curve of 0.732.
- Calibration analysis confirmed no significant over- or under-estimation or dispersion of predicted risk.
Conclusions:
- Accurate prediction of individual risk for severe COVID-19 is achievable through integrated clinical and genetic modeling.
- This predictive tool holds significant importance in areas with limited vaccine availability or vaccine hesitancy.
- The model's utility is underscored by ongoing concerns regarding vaccine effectiveness against new variants and transmission dynamics.
Abstract:
Clinical and genetic risk factors for severe coronavirus disease 2019 (COVID-19) are often considered independently and without knowledge of the magnitudes of their effects on risk. Using severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) positive participants from the UK Biobank, we developed and validated a clinical and genetic model to predict risk of severe COVID-19. We used multivariable logistic regression on a 70% training dataset and used the remaining 30% for validation. We also validated a previously published prototype model. In the validation dataset, our new model was associated with severe COVID-19 (odds ratio per quintile of risk = 1.77, 95% confidence interval (CI) 1.64-1.90) and had acceptable discrimination (area under the receiver operating characteristic curve = 0.732, 95% CI 0.708-0.756). We assessed calibration using logistic regression of the log odds of the risk score, and the new model showed no evidence of over- or under-estimation of risk (α = -0.08; 95% CI -0.21-0.05) and no evidence or over-or under-dispersion of risk (β = 0.90, 95% CI 0.80-1.00). Accurate prediction of individual risk is possible and will be important in regions where vaccines are not widely available or where people refuse or are disqualified from vaccination, especially given uncertainty about the extent of infection transmission among vaccinated people and the emergence of SARS-CoV-2 variants of concern.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

